SEC Filings

Filing date	Form	Description	Filing Group	View
Apr 07, 2020	3	Initial filing by director officer or owner of more than ten percent.	3,4,5	0001209191-20-023890.pdf 0001209191-20-023890.rtf 0001209191-20-023890.xls View HTML
Apr 07, 2020	EFFECT	EFFECT	Other	9999999995-20-000699.xls View HTML
Apr 03, 2020	8-A12B	Registration of certain classes of securities 12(b) of the Securities Exchange Act	Registration Statements	0001193125-20-098367.pdf 0001193125-20-098367.rtf 0001193125-20-098367.xls View HTML
Apr 03, 2020	CORRESP	CORRESP	Other	0001193125-20-098342.xls View HTML
Apr 03, 2020	CORRESP	CORRESP	Other	0001193125-20-098325.xls View HTML
Apr 01, 2020	S-1/A	Amended Registration statement for face-amount certificate companies	Registration Statements	0001193125-20-093365.pdf 0001193125-20-093365.rtf 0001193125-20-093365.xls View HTML
Mar 16, 2020	S-1	Registration statement for face-amount certificate companies	Registration Statements	0001193125-20-074978.pdf 0001193125-20-074978.rtf 0001193125-20-074978.xls View HTML
Mar 12, 2020	D		Other	0001664710-20-000001.pdf 0001664710-20-000001.rtf 0001664710-20-000001.xls View HTML
Feb 27, 2020	DRS/A	Amendment to a previously filed DRS	Registration Statements	0000950123-20-002689.pdf 0000950123-20-002689.rtf 0000950123-20-002689.xls View HTML
Jan 21, 2020	DRS	Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy	Registration Statements	0000950123-20-000379.pdf 0000950123-20-000379.rtf 0000950123-20-000379.xls View HTML

Data provided by Kaleidoscope.

Follicular_Lymphoma_in_Bone_Marrow image